Searching News Database: Endo Pharmaceuticals
HSMN NewsFeed - 7 Aug 2023
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
HSMN NewsFeed - 16 Jun 2021
Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer
Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer
HSMN NewsFeed - 21 Aug 2019
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal(R) Nasal Spray
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal(R) Nasal Spray
HSMN NewsFeed - 6 Oct 2017
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
HSMN NewsFeed - 15 Jun 2017
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
HSMN NewsFeed - 27 Jan 2017
Pharmaceuticals Veteran George R. Stevenson Joins the GeneriCo Board of Directors
Pharmaceuticals Veteran George R. Stevenson Joins the GeneriCo Board of Directors
HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
HSMN NewsFeed - 18 Feb 2014
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 22 Jul 2013
Endo Health Solutions Names Don DeGolyer Chief Operating Officer of Pharmaceuticals
Endo Health Solutions Names Don DeGolyer Chief Operating Officer of Pharmaceuticals
HSMN NewsFeed - 10 Jun 2013
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
HSMN NewsFeed - 31 Oct 2011
Endo Pharmaceuticals to Relocate From Chadds Ford, Pa., to New Facilities in Malvern
Endo Pharmaceuticals to Relocate From Chadds Ford, Pa., to New Facilities in Malvern
HSMN NewsFeed - 3 Oct 2011
Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
Coronado Biosciences Appoints Noah D. Beerman as Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 20 Jun 2011
Endo Pharmaceuticals Successfully Completes Acquisition of American Medical Systems for $2.9 Billion
Endo Pharmaceuticals Successfully Completes Acquisition of American Medical Systems for $2.9 Billion
HSMN NewsFeed - 11 Apr 2011
Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion
Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion
HSMN NewsFeed - 19 Jan 2011
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
HSMN NewsFeed - 3 Nov 2010
Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
HSMN NewsFeed - 28 Sep 2010
Apax Partners to Sell Qualitest Pharmaceuticals to Endo Pharmaceuticals for $1.2 Billion
Apax Partners to Sell Qualitest Pharmaceuticals to Endo Pharmaceuticals for $1.2 Billion
HSMN NewsFeed - 28 Sep 2010
Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 13 Apr 2010
Penwest and Endo Enter Into Agreement With Barr to Settle Patent Litigation Over Opana(R) ER
Penwest and Endo Enter Into Agreement With Barr to Settle Patent Litigation Over Opana(R) ER
HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
HSMN NewsFeed - 10 Dec 2009
Vertex Pharmaceuticals Announces Appointment of Nancy J. Wysenski as Chief Commercial Officer
Vertex Pharmaceuticals Announces Appointment of Nancy J. Wysenski as Chief Commercial Officer
HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
HSMN NewsFeed - 29 Jan 2009
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
HSMN NewsFeed - 13 Mar 2008
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
HSMN NewsFeed - 12 Mar 2008
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
HSMN NewsFeed - 11 Feb 2008
Hi-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup
Hi-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup
HSMN NewsFeed - 27 Dec 2007
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
HSMN NewsFeed - 17 Dec 2007
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
HSMN NewsFeed - 15 Nov 2007
Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER
Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER
HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
HSMN NewsFeed - 10 Oct 2007
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
NuPathe Inc. Names Jerry McLaughlin as Vice President of Commercial Operations
HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
HSMN NewsFeed - 27 Jun 2007
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
HSMN NewsFeed - 8 May 2007
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
Biogen Idec and Vernalis Plc Announce the Start of Phase II Program of BIIB014 in Parkinson's Disease
HSMN NewsFeed - 2 May 2007
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
HSMN NewsFeed - 9 Apr 2007
Alpharma Announces New Sales and Marketing Leadership in its Pharmaceuticals Business
Alpharma Announces New Sales and Marketing Leadership in its Pharmaceuticals Business
HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
HSMN NewsFeed - 17 Jan 2007
Endo Pharmaceuticals Receives Subpoena From U.S. Department of Health and Human Services
Endo Pharmaceuticals Receives Subpoena From U.S. Department of Health and Human Services
HSMN NewsFeed - 19 Dec 2006
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 23 Jun 2006
Penwest Announces That Endo Reports Receiving Final FDA Approval for Oxymorphone ER
Penwest Announces That Endo Reports Receiving Final FDA Approval for Oxymorphone ER
HSMN NewsFeed - 8 May 2006
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual Migraine
Additional items found! 82
Members Archive contains
82 additional stories matching:
Endo Pharmaceuticals
(Password required)
Endo Pharmaceuticals
(Password required)
